News – Page 39 – Endpoints News

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

3 months ago

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

3 months ago

Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves

3 months ago

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

3 months ago

Lilly joins molecular glue field with Magnet deal worth up to $1.25B

3 months ago

CDC is investigating five hospitalizations after use of Valneva’s chikungunya vaccine

3 months ago

HHS’ vaccine injury panel in limbo after monthlong meeting delay

3 months ago

Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets

3 months ago

Drug policy veteran at CMS to depart on Friday

3 months ago

OpenAI meets cancer care

3 months ago

Verve is latest gene editing company to suffer setback, as Vertex walks away from pact

3 months ago

Teladoc reports $1B net loss as it works to turn around its business

3 months ago

Hansoh ends collaboration with Silence; Vir hunts for HBV drug partner

3 months ago

Can Bill Anderson save Bayer?

3 months ago

Merck mulls new site in Delaware; Granules India buys peptide CDMO

3 months ago

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial

3 months ago

Startup working on oral antibodies shares early ulcerative colitis data

3 months ago

FDA meeting to pick next winter's flu shot is canceled, in ominous sign for US vaccine policy

3 months ago

Medicare spending on common diabetes drugs skyrocketed, HHS inspector general finds

3 months ago

After rejection, Regeneron seeks accelerated approval of bispecific for only one of two types of lymphoma

3 months ago

AstraZeneca’s SERD hits primary endpoint in late-stage trial, but first-line potential remains uncertain

3 months ago

Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies

3 months ago

Harbour BioMed inks deal up to $395M; ORIC refines plans for two drugs

3 months ago

Updated: Lilly joins Trump administration to announce $27B manufacturing commitment

3 months ago

First page Previous page 36 37 383940 41 42 Next page Last page